1. Mechanism of Action: The Type II Inhibitor

Anastrozole is classified as a Type II (non-steroidal) inhibitor. This distinction is critical for understanding how it affects the body:

• Reversible Competition: It competes with natural substrates for access to the aromatase enzyme. Unlike Type I inhibitors (like Exemestane), it does not destroy the enzyme.
• Temporary Suppression: Once the drug is cleared from your system, the aromatase enzyme returns to its normal function.
• Potency: A dosage of 0.5 mg to 1 mg daily is capable of reducing serum estradiol (E2) levels by approximately 50% in men.

2. Application in Performance & Fitness

Athletes and bodybuilders utilize Anastrozole to halt the "aromatization" process—the conversion of excess androgens (testosterone) into estrogens.

• Benefit: Prevents estrogenic side effects such as gynecomastia (male breast tissue growth) and excessive water retention.
• Standard Protocol: In most cycles, 1 mg per day is typically the maximum required to prevent side effects, though many users find lower doses (0.25mg–0.5mg) effective depending on the compounds used.

3. Known Side Effects & Risks

While effective, the suppression of estrogen carries specific physiological risks:

• Common Symptoms: Nausea, vomiting, hot flashes, headaches, and mood changes (including depression).
• Physical Strain: Joint pain, weakness, and fatigue are frequent, as estrogen plays a role in joint lubrication and energy.
• Long-Term Concerns:
• Bone Density: Prolonged use can lead to a decrease in bone mineral density, potentially resulting in osteoporosis.
• Cardiovascular & Immune Health: Chronic low estrogen levels can negatively impact cholesterol profiles and immune system response.

4. Usage Guidelines

Due to the systemic stress caused by suppressed estrogen, it is generally recommended that usage be limited to a maximum of two months at any single time. This prevents the more severe consequences of long-term hormonal imbalance.